-
Johnson&Johnson unbinds Kenvue's $600 million deal to bid farewell to the skincare and beauty industry
Recently, Kenvue (KVUE. US) announced on its official website that Johnson&Johnson (JNJ. US) will sell its remaining 9.5% stake in the company to Goldman Sachs and JPMorgan Chase in a debt to equity ... -
Legendary Biology is rumored to have received a billion dollar acquisition offer, and the industry expects Johnson&Johnson to participate in the competition
On July 12th, the US stock market analysis website Seeking Alpha reported that according to Street Insider, domestic biotech company Legendary Biotech received a merger offer and hired investment ban ...